Phase 4 N=25 Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color
Plaque Psoriasis · Psoriasis
Primary: Number of Patients Who Achieved Treatment Success — 4; 0 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=150 Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
Fallopian Tube Cancer · Ovarian Cancer · Ovarian Neoplasms
Primary: Sensitivity and Specificity of Cytological Samples for Fallopian Tube Involvement — .143; .959 Proportion of Cytuity Cell Samples
N/A N=89 A Retrospective Study of the iTotal CR Knee Replacement System
Osteoarthritis
Primary: Knee Function — 113 degrees
N/A N=2,348 Vest Prevention of Early Sudden Death Trial and VEST Registry
Myocardial Infarction · Ventricular Dysfunction · Sudden Death
Primary: Sudden Death Mortality — 25; 19 Participants
Phase 1 N=17 Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Lung Cancer · Metastatic Cancer
Primary: Number of Participants With Dose Limiting Toxicities and Maximum Tolerated Dose (MTD) — 0; 2; 0; 0 Participants
N/A N=100 The SAPIEN 3 Ultra System in Intermediate Risk Patients With Symptomatic, Severe Aortic Stenosis
Aortic Valve Stenosis
Primary: Procedural Success — 100 Participants
Phase 3 N=838 Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Dermatitis · Dermatitis, Atopic · Eczema
Primary: Percentage of Participants Achieving Investigator's Global Assessment (IGA) Response of Clear (0) or Almost Clear (1) and a Reduction of Greater Than or Equal to (>=) 2…
N/A N=29 Effect of Angulus on Patient-elevation Compliance
Ventilator Adverse Event · Ventilator Associated Pneumonia · Hospital Acquired Condition
Primary: Compliance to Head of Bed Elevation to 30 Degree or More. — 37.3; 32.4 percentage of time
Phase 3 N=1,759 Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Rheumatoid Arthritis
Primary: Percentage of Participants Who Achieved an American College of Rheumatology (ACR) 20% Improvement (ACR20) Response at Week 12 — 76.6; 69.8; 70.5; 49.9 percentage of…
Phase 3 N=39 A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1
Primary Hyperoxaluria Type 1 (PH1)
Primary: Percent Change in 24-hour Urinary Oxalate Excretion Corrected for Body Surface Area (BSA) From Baseline to Month 6 — -11.8; -65.4 percent change — p=<0.0001
Phase 1 N=96 Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects
Chronic Obstructive Pulmonary Disease
Primary: Maximum Plasma Concentration (Cmax) - Budesonide — 459.308; 224.298 pg/mL
N/A N=42 Assessment of the Effectiveness of Local Ablathermy Radio Frequency Bronchial Tumors Primitive
Malignant Non-small Cell Neoplasm of Lung Stage Ia
Primary: Local Tumor Control Rate 1 Year After Percutaneous Radiofrequency Ablation (RFA) — 5 Participants
Phase 3 N=205 Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Proliferative Diabetic Retinopathy · Vitreous Hemorrhage
Primary: E-ETDRS Visual Acuity Letter Score (Area Under the Curve From Baseline) — 59.3; 63.0 units on a scale
Phase 3 N=1,539 Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older
Influenza Immunization · Healthy Volunteers
Primary: Geometric Mean Titers (GMTs) of Influenza Antibodies in Participants Aged 60-64 Years and Greater Than or Equal to (>=) 65 Years — 471; 248; 303; 178 titers
N/A N=34 COPD: Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks.
Malnutrition
Primary: Weight Changes — 2.3; 4.4 kg